YCBD — cbdMD Inc
AMEX · Healthcare · Drug Manufacturers - Specialty & Generic
$0.50
+$0.00 (+0.51%)
cbdMD Inc (YCBD) is a drug manufacturers - specialty & generic company listed on AMEX. It is led by T. Ronan Kennedy, based in 2101 Westinghouse Blvd, Charlotte, NC, United States, 28273, with about 42 employees. cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.
Latest reported YCBD revenue for 2025-06-30 was $4.6M. Net income was -$895.3K. Revenue was down 3.0% from 2025-03-31 to 2025-06-30. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
On the latest cached filing, YCBD to acquire platform ($30M) (8-K 2026-09-02). Exhibit numbers: Deal $30M. Why it matters: expects its identity to evolve to reflect the full breadth of consumer wellness it now serves. Transaction value about $30M Twinlab is the kind of brand equity that companies spend decades trying to build,… This YCBD stock page is the analysis view: what changed in the numbers, and why it matters for cbdMD Inc.
Use this YCBD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the YCBD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the YCBD SEC filings page. Lician reads the product cache first so this HTML stays unique to cbdMD Inc even when a live quote feed is slow.
What changed in YCBD
8-K · 2026-09-02
YCBD to acquire platform ($30M)
Why it matters
- expects its identity to evolve to reflect the full breadth of consumer wellness it now serves.
- Transaction value about $30M
- Twinlab is the kind of brand equity that companies spend decades trying to build,…
About cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.
YCBD Key Statistics
Market Cap
$7.21M
Volume
191,839
Previous Close
$0.49
Day Range
$0.49 – $0.53
P/E Ratio
0.28
P/B Ratio
0.78
EPS
-$1.79
Revenue
$19.48M
Net Income
-$152.80K
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-19.3%
Profit Margin
-0.8%
Employees
42
YCBD Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $19.48M | $24.16M |
| Cost of Revenue | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 |
| Net Income | -$152.80K | -$15.87M |
| EPS (Diluted) | -$1.79 | -$13.32 |
Total Assets
$10.58M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$2.45M
Operating Cash Flow
-$352.79K
Free Cash Flow
$0.00
cbdMD Inc Company Information
- CEO, CFO, Principal Executive Officer & Director
- T. Ronan Kennedy
- Headquarters
- 2101 Westinghouse Blvd, Charlotte, NC, United States, 28273
- Website
- www.cbdmd.com
- Phone
- 704 445 3060
- IPO / Founded
- 2019-04-29
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic